Literature DB >> 19330234

HTLV-1 and neurological conditions: when to suspect and when to order a diagnostic test for HTLV-1 infection?

Abelardo Q C Araújo1, Ana Claudia C Leite, Marco Antonio S D Lima, Marcus Tulius T Silva.   

Abstract

HTLV-1 is a retrovirus associated with a myriad of clinical conditions, especially hematological and neurological ones. Regarding nervous system diseases, it is of utmost importance to select those cases in which HTLV-1 infection could really be associated. This is particularly true for patients from endemic areas and for HIV-infected patients and drug users, since that these groups are at a higher risk for HTLV infection. This caution in selecting neurological patients for HTLV diagnostic tests is justified by the fact that in some circumstances the seropositivity may merely represent an epiphenomenon. In this paper we enroll some neurological conditions that have been associated with HTLV-1/2 infection in the literature and discuss the real need for HTLV-1/2 diagnostic tests in each one. Because HIV/HTLV-co-infected patients seem to be at an increased risk for neurological diseases development, a special consideration about this matter is also made.

Entities:  

Mesh:

Year:  2009        PMID: 19330234     DOI: 10.1590/s0004-282x2009000100036

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  10 in total

1.  Acute myelitis as presenting symptom of HIV-HTLV-1 co-infection.

Authors:  A Cucca; L Stragapede; L Antonutti; M Catalan; I Caracciolo; Romina Valentinotti; A Granato; P D'Agaro; P Manganotti
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

2.  Neurological symptoms and signs in HTLV-1 patients with overactive bladder syndrome.

Authors:  Davi Tanajura Costa; André Luiz Muniz Alves dos Santos; Néviton Matos de Castro; Isadora Cristina de Siqueira; Edgar Marcelino de Carvalho Filho; Marshall Jay Glesby
Journal:  Arq Neuropsiquiatr       Date:  2012-04       Impact factor: 1.420

3.  Prognosis Markers for Monitoring HTLV-1 Neurologic Disease.

Authors:  Gabriela Prates; Tatiane Assone; Marcelo Corral; Maíra P M Baldassin; Tatiane Mitiko; Flávia C Silva Sales; Michel E Haziot; Jerusa Smid; Luiz A M Fonseca; Fernanda de Toledo Gonçalves; Augusto C Penalva de Oliveira; Jorge Casseb
Journal:  Neurol Clin Pract       Date:  2021-04

Review 4.  HTLV-1, Immune Response and Autoimmunity.

Authors:  Juarez A S Quaresma; Gilberto T Yoshikawa; Roberta V L Koyama; George A S Dias; Satomi Fujihara; Hellen T Fuzii
Journal:  Viruses       Date:  2015-12-24       Impact factor: 5.048

5.  Central nervous system infiltration by HTLV-1-associated T-cell leukemia/lymphoma in an AIDS patient.

Authors:  Luzia Beatriz Ribeiro Zago; Vanessa Afonso da Silva; Fernanda Bernadelli De Vito; Leonardo Rodrigues de Oliveira
Journal:  Rev Soc Bras Med Trop       Date:  2020-06-12       Impact factor: 1.581

6.  Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: Association with high proviral load.

Authors:  Michel E Haziot; M Rita Gascon; Tatiane Assone; Luiz Augusto M Fonseca; Olinda do Carmo Luiz; Jerusa Smid; Arthur M Paiva; Rosa Maria do N Marcusso; A C Penalva de Oliveira; Jorge Casseb
Journal:  PLoS Negl Trop Dis       Date:  2019-05-01

7.  Neurologic, clinical, and immunologic features in a cohort of HTLV-1 carriers with high proviral loads.

Authors:  Sheila N Ferraz; Gabriela F Costa; José Abraão Carneiro Neto; Thiago Hebert; Cassius J V de Oliveira; Mariele Guerra; Lívia M A Oliveira; Edgar M Carvalho
Journal:  J Neurovirol       Date:  2020-05-08       Impact factor: 2.643

8.  Effects of Danazol on Clinical Improvement of Patients with Human T-cell Lymphotropic Virus Type I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Placebo-Controlled Clinical Trial.

Authors:  Reza Boostani; Hamidreza Saber; Mohammadmahdi Etemadi
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

9.  Vestibular-evoked myogenic potential triggered by galvanic vestibular stimulation may reveal subclinical alterations in human T-cell lymphotropic virus type 1-associated myelopathy.

Authors:  Ludimila Labanca; Júlia Fonseca de Morais Caporali; Sirley Alves da Silva Carvalho; José Roberto Lambertucci; Anna Bárbara de Freitas Carneiro Proietti; Luiz Cláudio Ferreira Romanelli; Paul Avan; Fabrice Giraudet; Bárbara Oliveira Souza; Kyonis Rodrigues Florentino; Denise Utsch Gonçalves
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

10.  HAM/TSP and major depression: the role of age.

Authors:  Ney Boa-Sorte; Ana Verena Galvão-Castro; Danilo Borba; Renan Barbalho Nunes de Castro Lima; Bernardo Galvão-Castro
Journal:  Braz J Infect Dis       Date:  2015-01-27       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.